Social Media Influencers Fueling Parallel Trade for Unapproved Slimming Medication

An underground economy for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.

Experimental Drug Gaining Traction Via Social Media

Retatrutide, which is still in research studies, is being advertised by social media influencers for its alleged fat-burning effects. Viewers are urged to contact these accounts directly for source information, while also obtaining discount codes.

Active Commerce on Social Networks

Separately, a flourishing trade exists on Telegram, where communities with numerous of members share “before and after” images, injection guides and claims of rapid British shipping. Vendors promote the drug there before directing customers to other platforms for transactions.

Learning About Retatrutide

This medication is an experimental injectable developed by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help patients lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Professionals Express Worries

Nevertheless, physicians and pharmacists have warned that the sale of what is still an unlicensed medication in the United Kingdom is a cause for concern and could result in users injecting substances of unknown origin.

Several professionals said the popularity for retatrutide could be connected to the increasing price of approved slimming treatments such as Mounjaro.

Legal Position and Enforcement

Selling the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.

Some content creators try to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still violate medicines, advertising, and customer laws, potentially leading to penalties, legal action or prison.

Service Reaction and Content Removal

According to TikTok, the platform has taken down problematic material and prohibited associated hashtags and search suggestions. The organization stated it was dedicated to keeping the platform secure and investing in enhancing compliance measures.

Digital Marketplace Activities

Investigations also found groups with up to nine thousand members selling retatrutide using Telegram's built-in discovery tool, which functions like a public directory. Entering “retatrutide” instantly displays channels with thousands of members, populated with photos of slimming results, glowing reviews and detailed guides for mixing or injecting at residence.

Within minutes of entering one group, a vendor posted contact information, where most purchases occur. The seller provided an instruction manual and guaranteed delivery within two days. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None asked about weight, health issues or previous experience.

Product Details and Costs

Inside these groups, messages show dark colored packages with postal service labels, stating to include new batches. One communication read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at residence with purified liquid, or pre-filled injectors usually priced at £160 for 20 milligrams. When asked how long a pen should last, sellers give conflicting answers ranging from a several days to “depends on your body”.

Platform Moderation and Security Actions

A representative for the messaging service said it regularly moderated dangerous material on its service including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are administering substances they can’t verify. Even if the science behind retatrutide is valid, these online products may not include what they claim,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to current price rises for approved slimming medications such as Mounjaro. “With prices increasing, patients are using social media. But counterfeit injections are highly risky. You can’t be certain what’s contained or whether the environment they were made in was clean,” she explained.

Her staff has already encountered patients harmed by personal administration from unconfirmed sources. “We understand the disappointment, but buying from Telegram or communication platforms is taking chances with your health,” said Wyllie. “These materials could be impure or improperly measured.”

Manufacturer Position

A representative from Eli Lilly stated retatrutide was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this time no one can sell [it] for personal consumption,” they said, adding that any item “falsely representing itself as a company experimental product not yet approved … may expose patients to potentially serious health risks”.

Jerome Horne
Jerome Horne

Award-winning journalist and tech analyst with over a decade of experience covering digital trends and media innovations across Europe.